Pyxis Oncology, Inc. – NASDAQ:PYXS

Pyxis Oncology stock price today

$1.2
-0.39
-24.53%
Financial Health
0
1
2
3
4
5
6
7
8
9

Pyxis Oncology stock price monthly change

-49.52%
month

Pyxis Oncology stock price quarterly change

-49.52%
quarter

Pyxis Oncology stock price yearly change

-8.62%
year

Pyxis Oncology key metrics

Market Cap
94.84M
Enterprise value
N/A
P/E
-1.1
EV/Sales
N/A
EV/EBITDA
0.19
Price/Sales
N/A
Price/Book
0.78
PEG ratio
-0.01
EPS
-1.38
Revenue
N/A
EBITDA
-64.44M
Income
-57.80M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Pyxis Oncology stock price history

Pyxis Oncology stock forecast

Pyxis Oncology financial statements

Pyxis Oncology, Inc. (NASDAQ:PYXS): Profit margin
Jun 2023 0 -15.90M
Sep 2023 0 -23.04M
Dec 2023 3.42M -15.59M -456.05%
Mar 2024 16.14M -3.25M -20.17%
Pyxis Oncology, Inc. (NASDAQ:PYXS): Analyst Estimates
Sep 2025 125K -13.38M -10709.66%
Oct 2025 125K -18.42M -14742.59%
Dec 2025 0 -15.16M
Dec 2025 125K -17.79M -14234.62%
  • Analysts Price target

  • Financials & Ratios estimates

Pyxis Oncology, Inc. (NASDAQ:PYXS): Earnings per share (EPS)
2024-03-21 -0.49 -0.33
2024-05-14 -0.27 -0.06
Pyxis Oncology, Inc. (NASDAQ:PYXS): Debt to assets
Jun 2023 175230000 29.95M 17.09%
Sep 2023 186692000 48.74M 26.11%
Dec 2023 173726000 48.02M 27.64%
Mar 2024 220220000 36.06M 16.38%
Pyxis Oncology, Inc. (NASDAQ:PYXS): Cash Flow
Jun 2023 -11.03M -22.25M 6.12M
Sep 2023 -17.58M 6.57M -171K
Dec 2023 -15.25M 10.22M -25K
Mar 2024 -20.71M -18.49M 57.51M

Pyxis Oncology alternative data

Pyxis Oncology, Inc. (NASDAQ:PYXS): Employee count
Aug 2023 73
Sep 2023 72
Oct 2023 72
Nov 2023 72
Dec 2023 67
Jan 2024 67
Feb 2024 67
Mar 2024 50
Apr 2024 50
May 2024 50
Jun 2024 51
Jul 2024 51

Pyxis Oncology other data

4.50% -56.04%
of PYXS is owned by hedge funds
1.48M -18.22M
shares is hold by hedge funds

Pyxis Oncology, Inc. (NASDAQ:PYXS): Insider trades (number of shares)
Period Buy Sel
Nov 2024 88850 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
CONNEALY PAMELA ANN officer: CFO & COO
Common Stock 83,400 $1.96 $163,464
Purchase
CONNEALY PAMELA ANN officer: CFO & COO
Common Stock 5,450 $2 $10,900
Purchase
CONNEALY PAMELA ANN officer: CFO and COO
Common Stock 8,000 $1.87 $14,960
Purchase
WADHANE JITENDRA officer: Chief Accounting Officer
Common Stock 2,500 $1.87 $4,675
Purchase
CONNEALY PAMELA ANN officer: CFO and COO
Common Stock 6,426 $1.85 $11,869
Purchase
WADHANE JITENDRA officer: Chief Accounting Officer
Common Stock 5,000 $1.77 $8,850
Purchase
CONNEALY PAMELA ANN officer: CFO and COO
Common Stock 12,000 $1.67 $20,040
Purchase
WADHANE JITENDRA officer: Chief Accounting Officer
Common Stock 2,500 $1.74 $4,350
Purchase
CONNEALY PAMELA ANN officer: CFO and COO
Common Stock 5,000 $1.74 $8,695
Sale
SULLIVAN LARA director, officer: President an..
Common Stock 8,541 $2.1 $17,936
Thursday, 19 December 2024
globenewswire.com
Saturday, 7 December 2024
seekingalpha.com
Thursday, 21 November 2024
benzinga.com
Wednesday, 20 November 2024
globenewswire.com
Friday, 8 November 2024
benzinga.com
Wednesday, 25 September 2024
prnewswire.com
Friday, 13 September 2024
seekingalpha.com
Thursday, 29 August 2024
globenewswire.com
Wednesday, 14 August 2024
globenewswire.com
Monday, 29 July 2024
globenewswire.com
Friday, 28 June 2024
globenewswire.com
Monday, 10 June 2024
globenewswire.com
Thursday, 30 May 2024
globenewswire.com
Monday, 20 May 2024
https://www.defenseworld.net
Tuesday, 14 May 2024
Zacks Investment Research
Friday, 12 April 2024
Zacks Investment Research
Wednesday, 27 March 2024
InvestorPlace
Tuesday, 26 March 2024
Zacks Investment Research
Tuesday, 19 March 2024
InvestorPlace
Thursday, 7 March 2024
GlobeNewsWire
Tuesday, 5 March 2024
GlobeNewsWire
Thursday, 22 February 2024
InvestorPlace
Monday, 21 August 2023
Zacks Investment Research
Tuesday, 1 August 2023
GlobeNewsWire
Monday, 17 July 2023
Zacks Investment Research
Monday, 12 June 2023
Seeking Alpha
Wednesday, 31 May 2023
Zacks Investment Research
Monday, 15 May 2023
PennyStocks
Wednesday, 29 March 2023
PennyStocks
Tuesday, 28 March 2023
PennyStocks
  • What's the price of Pyxis Oncology stock today?

    One share of Pyxis Oncology stock can currently be purchased for approximately $1.2.

  • When is Pyxis Oncology's next earnings date?

    Unfortunately, Pyxis Oncology's (PYXS) next earnings date is currently unknown.

  • Does Pyxis Oncology pay dividends?

    No, Pyxis Oncology does not pay dividends.

  • How much money does Pyxis Oncology make?

    Pyxis Oncology has a market capitalization of 94.84M. Pyxis Oncology made a loss 73.79M US dollars in net income (profit) last year or -$0.06 on an earnings per share basis.

  • What is Pyxis Oncology's stock symbol?

    Pyxis Oncology, Inc. is traded on the NASDAQ under the ticker symbol "PYXS".

  • What is Pyxis Oncology's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Pyxis Oncology?

    Shares of Pyxis Oncology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Pyxis Oncology's key executives?

    Pyxis Oncology's management team includes the following people:

    • Dr. Ronald Herbst Ph.D. Chief Scientific Officer(age: 64, pay: $468,600)
  • How many employees does Pyxis Oncology have?

    As Jul 2024, Pyxis Oncology employs 51 workers, which is 2% more then previous quarter.

  • When Pyxis Oncology went public?

    Pyxis Oncology, Inc. is publicly traded company for more then 3 years since IPO on 8 Oct 2021.

  • What is Pyxis Oncology's official website?

    The official website for Pyxis Oncology is pyxisoncology.com.

  • Where are Pyxis Oncology's headquarters?

    Pyxis Oncology is headquartered at 35 Cambridgepark Drive, Cambridge, MA.

  • How can i contact Pyxis Oncology?

    Pyxis Oncology's mailing address is 35 Cambridgepark Drive, Cambridge, MA and company can be reached via phone at +61 72219059.

Pyxis Oncology company profile:

Pyxis Oncology, Inc.

pyxisoncology.com
Exchange:

NASDAQ

Full time employees:

54

Industry:

Biotechnology

Sector:

Healthcare

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therapeutic for treatment of solid tumors. The company's antibody drug conjugate (ADC) product candidates comprise of PYX-201, an investigational novel ADC to treat NSCLC, breast cancer, and other solid tumors; PYX-202, an investigational novel ADC for treatment of SCLC, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational ADC for the treatment of acute myeloid leukemia and myeloid dysplastic syndrome. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

35 Cambridgepark Drive
Cambridge, MA 02140

CIK: 0001782223
ISIN: US7473241013
CUSIP: 747324101